Legal Information

Site Editor

51蹤獲
WELLIO – SILEX 2
9-13 rue des Cuirassiers
69003 LYON, FRANCE
+33 (0)4 37 70 02 19
Email: contact@enyopharma.com
SIREN: 799 831 011 RCS Lyon
Publishing Director:Jacky Vonderscher, CEO

Hosting

Hosting is provided by
Address: 33, place bellecour, 69002 Lyon, FRANCE
contact@iilyo.com

No warranty and no liability

While 51蹤獲SA is making best efforts to include accurate and up-to-date information, we make no representations or warranties, express or implied, as to the accuracy or completeness of the information provided on this Website and disclaim any liability for the use of this site or any site linked to it. 51蹤獲may change this site at any time without notice but does not assume any responsibility to update it. Neither 51蹤獲 nor any other party involved in creating, producing or delivering this Website or on any Website linked to from this site shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Website or any Website linked to from this site, or any errors or omissions in the content thereof.

Forward-looking information

This page may contain forward-looking information and estimates with respect to 51蹤獲s clinical trials, clinical trial data releases, clinical development plans and anticipated future activities of 51蹤獲. Certain of these statements, forecasts and estimates can be recognized by the use of words such as, without limitation, believes, anticipates, expects, intends, plans, seeks, estimates, may, will and continue and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management’s beliefs.. Such information is subject to a variety of significant uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly from those presented. There can be no guarantees with respect to pipeline product candidates that the clinical trial results will be available on their anticipated timeline, that future clinical trials will be initiated as anticipated, or that candidates will receive the necessary regulatory approvals. Given these risks and uncertainties, no representations are made as to the accuracy or fairness of such forward-looking statements, forecasts and estimates. Furthermore, forward-looking statements, forecasts and estimates only speak as of the date of their disclosure. Readers are cautioned not to place undue reliance on any of these forward-looking statement.

Links

Links to third party pages are provided for convenience only. We do not express any opinion on the content of any third party pages and expressly disclaim any liability for all third party information and the use of it.

Trademarks

All mentioned trademarks are owned by or licensed to 51蹤獲SA. Use of the trademarks owned by 51蹤獲 and/or its products without prior authorization is prohibited.

Copyright

The Website of 51蹤獲SA and the information contained and referenced therein are for informational purposes only. Any reproduction, retransmission or other use is strictly prohibited. Request for permission to reproduce any information contained on this Website should be addressed to 51蹤獲SA.